Prev Close | 189.75 |
Open | 191.91 |
Day Low/High | 189.16 / 192.18 |
52 Wk Low/High | 174.42 / 236.86 |
Volume | 2.22M |
Prev Close | 189.75 |
Open | 191.91 |
Day Low/High | 189.16 / 192.18 |
52 Wk Low/High | 174.42 / 236.86 |
Volume | 2.22M |
Exchange | NASDAQ |
Shares Outstanding | 680.73B |
Market Cap | 131.14B |
Div & Yield | N.A. (N.A) |
The technical signals of the industrial and technology giant just aren't bullish enough to recommend going long right now.
It was as if equity markets had taken the day off. Not bond markets, however.
Here's what traders may want to do now.
Disappointment Perhaps because I think highly of CEO Darius Adamczyk. Though in his defense he did admit last week that the supply chain struggles now hitting almost all goods producing companies took him by surprise. Perhaps it's just because I am ...
It's great to be filling in again for Doug Kass at the Daily Diary. Friday. Friday. Friday. Hope you're ready. I know I am. Markets have turned for the better overnight as Evergrande delayed impending doom, despite semi-negative to profoundly negati...
Plus, Snap Inc. disappoints with its guidance as Apple lets users opt out of being tracked by individual apps.
ETN has been in a strong uptrend the past 12 months.
This COVID-19 vaccine is the potential savior of more than just the market.
HON's outstanding quarter shows they're hitting on all cylinders while increasing margin in the process.
Plus, what could be next out of the central banks and Congress and how it could affect Treasuries.
Good morning one and all, I'm Chris Versace, filling in for Doug Kass on the Daily Diary, and if you were expecting a sleepy summer Friday, not only do we have a bunch of quarterly earnings reports from American Express , Honeywell , Kimberly-Clark ...
Also, there's reason to turn J&J's one shot jab into a two shot vaccine just like the rest.
Here's where aggressive traders could go long HON at current levels.
The first step is to recognize what is going on as major indices go one way and speculative stocks go another.
Let's look at the companies that can go up, and the ones that can't.
This is that 72-hour period when the most important names report. Here's what you need to know to get through it.
Getting dizzy looking down from here? Then look up, because we may just be getting started on this market.
My target price has been $260 for HON for some time. I see no reason to change that now.
The president's plans to raise taxes aren't a surprise, but hiking the capital gains rate significantly isn't such a hot idea.
Don't fear the taxman, view this one as an opportunity, not a penalty.
Amazingly, one group isn't just left behind, it just keeps losing money, while the other group is shrugging off this day with aplomb.
Fundamentals and valuations are secondary to shifting money into certain sectors.
BA may be a buy on this weakness. The charts show some pressure in the short-term, but longer-term, the skies are clearing.
It may seem ridiculous, but you can distill the market down to these two names because they stand for palpable themes.
The near-term direction of the technology and manufacturing giant's shares isn't clear from its technical patterns.
Tuesday was a quirky sort of day that came ahead of the FOMC policy decision set for this (Wednesday) afternoon.